NattoPharma enters partnership with KD Pharma
NattoPharma and KD Nutra have entered into a partnership agreement to promote KD-PüR® high concentrate Omega-3s and MenaQ7® PharmaPure MK-7 combinationOslo, Norway (24 june 2020) — NattoPharma has entered into a partnership agreement with KD Nutra – a KD Pharma Group company – to create an innovative cardiovascular-support ingredient that combines KD Nutra’s KD-PüR® high concentrate omega-3s with NattoPharma’s category leading nature-identical Vitamin K2, MenaQ7® PharmaPure MK-7. The exclusive partnership for KD-Pür® EPA and DHA ≥ 70% Concentrates and MenaQ7® K2 is available as part of